+ All Categories
Home > Documents > Dr. Hefziba Green Nephrology & Hypertension

Dr. Hefziba Green Nephrology & Hypertension

Date post: 09-Nov-2021
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
31
Dr. Hefziba Green Nephrology & Hypertension Rabin medical center
Transcript

Dr. Hefziba Green Nephrology & Hypertension

Rabin medical center

A Brief History 27 years old woman. Married + 2 (twins) 2008- Diagnosis of Ulcerative colitis during

pregnancy. Constant elevation of cholestatic liver enzymes.

2/2010 –MRCP – features compatible with PSC

The disease is steroid dependent, multiple flares. Suggested treatments: Remicade, collectomy

Present 12/5/12 – admission after 2 weeks of fatigue, malaise,

nausea, anorexia, arthralgia (ankles) and pre-syncope Diarrhea without change from baseline, 4-5 times a day,

with no blood or mucus. No fever, BP 138/89, SaO2 normal The day before her admission - IV Venofer for the first time

to treat known iron deficiency anemia Current medication:

T. ASACOL 4 G/D T. PURINETHOL(6MP) 75 MG/D T. PREDNISONE 5 MG/D

Lab results (Jan-May 2012) 2/5/12 27/3/12 31/1/12

7300 7000 6400 WBC

10.4 9.8 10.6 Hb

106 110 109 MCV

461,000 391,000 612,000 Plt

12.3 9.2 MPV

17% 17.6% RDW

26% 23% Transferin sat.

13 10 42 Ferritin (ng/ml)

Lab results (Jan- May 2012) 2/5/12 27/3/12 31/1/12

429 255 253 B12 (pmol/L)

14.3 14.1 FA (nmol/L)

0.56 Creatinine (mg/dl)

3.4 Albumin (g/dl)

0.5 Bilirubin (mg/dl)

NORMAL GOT/GPT

165 Alk. Phos (35-105 U/L)

On admission 134 Sodium (mEq/l) 9580 WBC

4.5 Potassium (mEq/l) 7.2 Hb

2.5 Albumin (g/dl) 91.5 MCV

2.36 (indirect) Bilirubin 93,000 Plt

160 GOT (0-31 U/l) 7.3 MPV

69 GPT (0-34 U/L) 157 K/micl Abs. reticulocytes

186 Alk. Phos (30-120 U/L)

1.56 INR

6247 LDH (230-480 U/L)

44 APTT (sec)

164 Iron (4-145 mcg/dl)

319 Fibrinogen (200-530 mg/dl)

135 Transferrin (200-360 mg/dl)

3.97 Creatinine (mg/dl)

168 Urea

Urinalysis : protein 500 mg/dl, erythrocyte casts, few granulr casts

Blood smear: extremely pathologic red cells with target cells, schistocytes, polychromasia, Howell-Jolly bodies

Negative direct Coombs test

Microangiopathic Hemolytic Anemia m/p TTP/HUS

Plasma exchange + IV Hydrocortisone

The first few days Daily plasma exchange

15/5/12 14/5/12 13/5/12 12/5/12

160/100 129/90 122/87 138/89 BP

7.7 8.5 8.1 7.2 Hb

35,000 33,000 42,000 93,000 Plt

3.52 3.77 3.74 3.97 Creatinine (mg/dl)

4173 3732 3376 6247 LDH (U/L)

Some answers Haptoglobin below detection level Negative bHCG Viral serology:

HBsAg - Neg HBsAb>1000 ,HCV – Neg ,HIV -Neg CMV IgG – Pos CMV IgM – Neg EBV-EBNA - Pos

Clotting factors (during PE) Factors V, VII, VIII, IX, X- all within normal values

FACS for the detection of PNH clone CD59-100% ,Monocytes + Granulocytes FLAER -100% ,

Granulocytes CD24-100%

15/5/12 – ADMATS 13 - normal

So, HUS than… 6MP was discontinued in the 2nd admission day

Admission day 4- positive stool test for Clostridium dif. Ag, negative for CD toxin. Started on Flagyl.

Stool cultures - negative

15/5/12 – Mensevax

16-17/5/12 – more results are coming:

ANA- titer 1:80 APLA – Neg Anti MPO – Neg Anti PR3 – Neg RF - Normal SCL-70 - Neg SSA/ SSB – Neg RNP –Neg

C3 – 82.8 mg/dl (90-180) C4 – 7.3 mg/dl (10-40)

Admission day 10 After 9 sessions of PE and high-dose steroids

Clincal evaluation: No change in diarrhea frequency. PCR-CD from blood is

negative- flagyl discontinued after 5 days. She’s hypertensive, diastolic BP>100, anasarca– started

on diuretics and later on calcium channel blockers

Lab results: No change is Hb, Plt., LDH, Creatinine 20/5/12- in 24 hours urine collection proteinuria of 14.5

g/d, same results 2 days later

Biopsy 22/5/12

23-27/5/12- ICU. PC infusion, PE resumed after 48 hours 27/5/12 – Back in internal medicine department

After 12 sessions of PE

22/5/12 for the 1st time LDH<2000 and did not rise between sessions

30/5/12 platelets up to 120,000 without infusions

Creatinine level began to decline, but “got stuck” on 2.6 mg/dl

30/5/12 started on Rafapen

IV ECULIZUMAB

31/5/12

Eculizumab Half life of approximately 11 days following IV

administration. Distributed in the vascular space The inhibition of complement activation at the

level of C5 creates a functional C5 deificiency Blockade of the complement cascade at the C5

level does preserve the early components of complement that are essential for the opsonization of microorganisms and the clearance of immune complexes

Increased risk for Neisseria meningitides

Dramatic response First goes the platelets

146,000 at 31/5 * 160,000 at 1/6 * 309,00 at 4/6

Next come the kidneys

2.42 mg/dl at 4/6 * 2.17 mg/dl at 7/6 * 1.67 mg/dl at 9/6 * 1.56 mg/dl at 12/6

The hemoglobin takes its time getting to 10 mg% only after 3 weeks

LDH is last

1600 at 7/6 * 1112 at 17/6

5/6/12 discharged home

And since then… C3, C4 – normalized and stays within normal range

since 10/6/12 Hb around 12.0, Plt and LDH within normal range,

haptogobin high-normal Creatinine level declined gradually for the next few

weeks, currently around 1.05 mg/dl. No proteinuria BP improving, however still receiving calcium

channels blockers, beta blockers, ACE inhibitors

Slow tapering of steroids, no UC flares up

Anti CFH Ab 2000 AU/ ml

Monitoring complement blockade CH50 assays A useful tool for detecting a deficiency of the

classical pathway by assessing the ability of serum to lyse sheep erythrocytes

All nine components of the classical pathway (C1-C9) are required in order to reach a normal CH50 level

A blockade of C5-9 complex by eculizumab would result in low levels of CH50

מציג
הערות מצגת

Recommended